Bigul

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 3rd February, 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India, 380 060 which commenced at 3:00 P.M. and concluded at 4:00 P.M. inter-alia has, considered and approved: 1. Appointment of Ms. Gitika Mishra as Company Secretary and Compliance officer of the Company w.e.f. 3rd February, 2024. 2. Appointment of Ms. Payal Patel (DIN: 05300011) as Managing Director of the Company w.e.f 3rd February, 2024. 3. Resignation of Mr. Bhumishth Patel (DIN:02516641) from Managing Director of the Company w.e.f. 3rd February, 2024. 4. Decided to hold Extra Ordinary General Meeting of the Company on Wednesday, 28th February, 2024 at 4:00 PM.
03-02-2024
Bigul

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 22Nd January, 2024

Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd January, 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India, 380 060 which commenced at 2:00 P.M. and concluded at 3:00 P.M. interalia has, considered and approved as per attachment.
22-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 22Nd January, 2024

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 ,inter alia, to consider and approve and discuss proposal of raising of funds by way of issue of Equity shares on preferential allotment basis for cash consideration, subject to the receipt of necessary approvals. Further, pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, we hereby inform you that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Tuesday, 16th January, 2024 till 48 hours after the conclusion of the meeting.
16-01-2024

EVOQ Remedies tanks 16%, down 24% in two days after promoters' dramatic stake sale

On January 10, EVOQ Remedies said it secured a Rs 136- crore order, leading to a 20% spike in prices but soon promoters dumped 72% of their stake. It ended 8 percent lower on January 12
15-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel
12-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel
12-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Bhumishth Patel
12-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Bhumishth Patel
12-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st December, 2023
10-01-2024
Bigul

Evoq Remedies Ltd - 543500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 - Export Order of Rs. 136 Crores as per attachment.
10-01-2024
Next Page
Close

Let's Open Free Demat Account